ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

DRCCA To Get Name Change, Three Major Program Areas

August 27, 1982

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

Hoogstraten Resignation Sidetracks Kansas’ Move to Comprehensive Status, Threatens Core Grant

February 15, 1980

NIH Panel Calls For More Attention to Cancer Pain

July 26, 2002

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

How Cancer Control Grants, Contracts Distributed By States

October 13, 1978